Skip to content

A Single-Center Retrospective Cohort Study on the Analysis of Prognostic Factors in Patients with Myocarditis

A Single-Center Retrospective Cohort Study on the Analysis of Prognostic Factors in Patients with Myocarditis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114786
Enrollment
Unknown
Registered
2025-12-17
Start date
2025-12-20
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myocarditis

Interventions

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diagnosed with myocarditis at this center during the study period; 2. Having available baseline data (demographics, symptoms/signs, laboratory tests, imaging/EMB [if applicable], and treatment records); 3. Having at least one source of trackable outcome information (hospital records, readmissions, outpatient follow-ups, telephone follow-ups, death registries, etc.).

Exclusion criteria

Exclusion criteria: 1. Having alternative diagnoses that can fully explain myocardial injury (such as acute coronary syndrome with significant coronary stenosis, stress-induced cardiomyopathy, peripartum cardiomyopathy, previously diagnosed dilated/hypertrophic/restrictive cardiomyopathy, etc.); 2. Having a dominant phenotype of structural heart disease (moderate to severe valvular heart disease, complex congenital heart disease, etc.); 3. Having missing key baseline/outcome data that prevent the completion of the primary analysis. 4. Multiple admissions: Only the first admission is retained for each patient (subsequent admissions are considered as follow-up events).

Design outcomes

Primary

MeasureTime frame
All-cause death or cardiac transplantation (whichever occurs first);

Secondary

MeasureTime frame
In-hospital and 30/90-day outcomes: in-hospital death, use of VA-ECMO/IABP/Impella, AKI, severe arrhythmias, pacemaker/ICD implantation.;Mid-to-long-term outcomes: rehospitalization for heart failure, recurrence of non-fatal ventricular arrhythmias, new-onset/recurrent atrial fibrillation, and recurrent myocarditis.;Laboratory and biomarkers: Cardiac troponin (cTnI/T), NT-proBNP/BNP, CRP, renal function (creatinine/eGFR), and electrolytes.;Imaging/Function: Changes in LVEF, LVEDD, left atrial volume index, E/e', CMR LGE extent/distribution, native T1/T2, and ECV.;Functional recovery and recurrence: The proportion and time of LVEF recovery to >=50% or an absolute increase of >=10% from baseline; recurrent myocarditis;

Countries

China

Contacts

Public ContactRong Jiang

Shanghai General Hospital

listening39@163.com+86 21 6324 0090

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026